Clinical Efficacy and Safety of Lacosamide as an Adjunctive Treatment in Adults With Refractory Epilepsy

Background: Lacosamide (LCM), a novel AED (antiepileptic drug), was used as an adjunctive treatment in patients with partial-onset seizures or without secondary generalization. However, no meta-analysis was performed to evaluate the efficacy of LCM as an adjunctive treatment in post-marketing clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Liyan, Peng, Bingjie, Zhang, Defu, Yang, Jingjing, Wang, Ying, Tong, Li, Li, Sheng, Wang, Qingshan, Zhao, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677652/
https://www.ncbi.nlm.nih.gov/pubmed/34925202
http://dx.doi.org/10.3389/fneur.2021.712717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677652/
https://www.ncbi.nlm.nih.gov/pubmed/34925202
http://dx.doi.org/10.3389/fneur.2021.712717

Ejemplares similares